Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Xcel Energy Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Xcel Energy Inc trades at $75.55 (market cap $46.62B). The key difference: Xcel Energy Inc is far larger — about 5.5× Hinge Health Inc. Class A Common Stock's market cap, and Xcel Energy Inc pays a 3.18% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Xcel Energy Inc for 61 Days on average.
| HNGE | XEL | |
|---|---|---|
Market Cap | $8.48B | $46.62B |
Volume | 879,799 | 4,168,668 |
Sector | Health | Utilities |
52-Week High | $105.14 | $83.91 |
52-Week Low | $31.17 | $69.39 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $8.10B | $84.94B |
Dividend Yield | — | 3.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Xcel Energy (XEL) trades at $75.36, up 1.6% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings show mixed results with a Q2 2026 beat (EPS $0.93 vs. $0.79 expected) but a Q4 2025 miss. Revenue for 2025 was $14.67B with a net income margin of 15.28%, while the company maintains a P/E of 20.45 and ROE of 9.92%. News highlights include partnerships for electric school buses and growth from data center power demand.
The outlook is positive, supported by a $60 billion capital expenditure plan and rising power demand, offering potential upside to the $90.58 consensus price target. Key risks include wildfire liabilities, high debt levels, and regulatory scrutiny. The stock presents a balanced opportunity for income and growth investors, with a dividend yield around 3.3% and institutional accumulation noted in recent filings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
